öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÂíÏè
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º44

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Ö÷ÒªÖÂÁ¦ÓÚÒÅ´«±äÐÔÑ۵ײ¡µÄ»ùÒòÕï¶Ï¡¢»ùÒòÖÎÁƼ°¸Éϸ°ûÌæ´úÖÎÁƵȵÄÑо¿
Ñо¿ÁìÓò£º Ö÷ÒªÖÂÁ¦ÓÚÒÅ´«±äÐÔÑ۵ײ¡µÄ»ùÒòÕï¶Ï¡¢»ùÒòÖÎÁƼ°¸Éϸ°ûÌæ´úÖÎÁƵȵÄÑо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºxma9467@vip.sina.com


¸öÈ˼òÊö :
ÂíÏ裬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦¡£´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÑÛ¿ÆÖ÷ÈΣ¬ÑۿƽÌÑÐÊÒÖ÷ÈΣ¬Ò½Ôº×ÛºÏÍâ¿Æ×ÜÖ§Êé¼Ç¡£±±¾©´óѧÑۿƲ©Ê¿£¬ÃÀ¹úÊÀ½çÖøÃûÑÛ¿ÆÑо¿Ëù²©Ê¿ºó5Äê¡£ÏÖÈιú¼ÊÑÛ¿ÆÑо¿Ñ§»á£¨ISER£©Î¯Ô±£¬¹ú¼ÊÊÓ¾õÓëÑÛ¿ÆÑо¿Ñ§»á£¨ARVO£©¼°ÃÀ¹úÑÛ¿Æѧ»á£¨AAO£©»áÔ±£¬ÖлªÒ½Ñ§»áÑÛ¿Æѧ»áίԱ¡¢Öйúҽʦѧ»áÑÛ¿Æ·Ö»áίԱ£¬ÖлªÒ½Ñ§»á¶ù¿Æѧ·Ö»áÑÛ¿Æѧ×鸱×鳤£¬ÖлªÑÛ¿Æѧ»áÑ۵ײ¡Ñ§×éίԱ£¬ÁÉÄþÊ¡ÑÛ¿Æѧ»áºîÈÎÖ÷ÈÎίԱ£¬ÁÉÄþÊ¡ÑÛÍâÉË¿µ¸´Ñ§»á¡¢Ê¡ÖÐÎ÷Ò½ÑÛ¿Æѧ»á¸±Ö÷ÈÎίԱ£¬ÁÉÄþÊ¡ÑÛ¿ÆÖصãר¿Æ£¨´óÒ½Ò»Ò½Ôº£©Ö÷ÈΣ¬´óÁ¬ÊÐÑÛ¿Æѧ»áºòÈÎÖ÷ÈÎίԱ£¬´óÁ¬ÊÐÑÛ¿ÆÖÊ¿ØÖÐÐÄÖ÷ÈΣ¬´óÁ¬ÊÐÑÛ¿ÆÖصãѧ¿ÆÖ÷ÈΣ¬É½¶«ÖÐÒ½Ò©´óѧ¿Í×ù½ÌÊÚ¡£ÖйúÀÏÄêҽѧѧ»áÑÛ¿Æѧ·Ö»á³£Î¯£¬º£Ï¿Á½°¶Ò½Ò©ÎÀÉú½»Á÷Э»áÑÛ¿ÆѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áίԱ, º£Ï¿Á½°¶Ò½Ñ§»á»Æ°ß²¡Ñ§×éίԱ¡¢²£Á§ÌåÊÓÍøĤѧ×éίԱ¡¢ÑÛµ×Ѫ¹Ü¼²²¡Î¯Ô±»áίԱ£¬ÖйúÒ½´Ù»áÀÏÄêÒ½ÁƱ£½¡·Ö»áÑÛ¿Æѧ×éίԱ£¬¹ú¼ÒÅ·ÃÀͬѧ»áÑÛ¿Æѧ·Ö»áίԱ£¬Öйú¶íÂÞ˹ÑÛ¿Æ·Ö»áίԱ£¬ÖлªÑÛ¿Æ·Ö»áÖÊÁ¿¿ØÖÆר¼Ò¹ËÎÊ×éίԱ£¬¹ú¼ÒÑÛ¿ÆÖÊ¿ØÖÐÐÄίԱ£¬¹ú¼ÒÑ۵ײ¡×¨¼Ò¹ËÎÊίԱ»áίԱ£¬¹ú¼ÒÊÓ¹âѧ׼·Ö×ÓÅàѵ£¨´óÁ¬»ùµØ£©Ö÷ÈεÈ¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð4Ïʡ²¿¼¶¿ÎÌâ13Ï¸±Ö÷±à¡¶ÑÛ¶ú±Çºí¿ÚÇ»¿Æѧ¡·, ²Î±à¹ú¼ÒÊ®¶þÎ塢ʮÈýÎåͳ±à¡¶ÑÛ¿Æѧ¡·¸ßµÈҽѧԺУ½Ì²Ä¸÷Ò»²¿µÈרÖø¶à²¿¡£·¢±íÎÄÕÂ60Óàƪ£¬È«Îļ°ÕªÒªSCIÊÕ¼25ƪ¡£¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬Öصã¡¢ÖØ´óÏîÄ¿£¬½ÜÇàµÈ9Ïî»ù½ðµÄ¶þÉóר¼Ò£¬¡¶ÖлªÑ۵ײ¡¡·µÈ9±¾ÔÓÖ¾±àί£¬¡¶BJO¡·µÈ8±¾¹ú¼ÊÖøÃûÑÛ¿ÆÔÓÖ¾Éó¸åÈË¡£ÈÙ»ñ¹ú¼ÊÑÛ¿ÆÑо¿Ñ§»á°ä·¢µÄ¡°Í»³öÑо¿½±¡±£¬ÁÉÄþÊ¡¿Æѧ¼¼Êõ½ø²½¶þµÈ½±2Ïî¡¢ÁÉÄþʡҽѧ¿Æѧ¼¼Êõ½ø²½ÈýµÈ½±1Ïî¡¢´óÁ¬ÊпƼ¼½ø²½½±Ò»µÈ½±1ÏîµÈ½±Ïî¡£ÊÇÁÉÄþÊ¡ÓÅÐã¹²²úµ³Ô±£¬ÁÉÄþÊ¡¡°³ÏÐÅ·þÎñ±­¡±ÏȽø¸öÈË£¬´óÁ¬ÊÐÕþЭίԱ, Å·ÃÀͬѧ»á¡¤ÖйúÁôѧÈËÔ±ÁªÒê»á»áÔ±£¬´óÁ¬º£ÍâÁªÒê»á¸±»á³¤£¬´óÁ¬±±ÃÀͬѧ»á¸±»á³¤, ´óÁ¬ÊÐÊ®´ó¿Æ¼¼±ê±ø£¬´óÁ¬ÊÐÊ®´ó½Ü³öÇàÄ꣬´óÁ¬°ÙÐÕ·ÅÐĺôó·ò£¬µÚÈý½ì´óÁ¬Áôѧ¹é¹ú´´ÒµÓ¢²ÅµÈ¡£

¿ÆÑй¤×÷ :
¿ÆÑпÎÌ⣺1.¸Éϸ°ûÒÆÖ²ÖÎÁƽÇĤԵ¸Éϸ°ûȱËð¼²²¡£¨´óÁ¬Ò½¿Æ´óѧת»¯Ò½Ñ§×¨Ïî»ù½ðÏîÄ¿£¬2016.01-2018.12£¬10ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
2.¿Í¹Û½á¹¹»¯öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¨OSCE£©ÔÚÑÛ¿ÆÁÙ´²½Ìѧ¿¼ÆÀÖеÄÑо¿Óëʵ¼ù£¨ÁÉÄþÊ¡½ÌÓý¿Æѧ¹æ»®¿ÎÌ⣬2016.6-2018.6£¬10ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
3.¿µ°ØÎ÷ÆնԸ߶ȽüÊӻư߱äÐÔÁÆЧµÄÑо¿£¨2016°×Çó¶÷»ù½ð»áIITÑо¿ÏîÄ¿£¬2016.7-2019.6, 25ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
4.ÓÕµ¼¶àÄܸÉϸ°ûÀ´Ô´µÄÊÓÍøĤɫËØÉÏƤϸ°ûºÍ¹â¸ÐÊÜÆ÷ϸ°ûÒÆÖ²ÖÎÁÆÊÓÍøĤɫËرäÐÔµÄʵÑéÑо¿£¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2013.01 -2016.12£¬70ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
5.¹ÇËè¼ä³äÖʸÉϸ°û¹¤³Ì½ÇĤÄÚƤÖؽ¨µÄÑо¿£¨ÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð£¬2013.01-2014.12£¬5ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
6.ÑòĤ¸Éϸ°û×éÖ¯¹¤³Ì½ÇĤÄÚƤÖؽ¨µÄÑо¿£¨´óÁ¬ÊпƼ¼¾ÖÏîÄ¿£¬2013.01-2014.12£¬5ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
7.ÑۿƸÉϸ°ûרÏîÑо¿£¨´óÁ¬Êз¢¸Äί×ÊÖúÏîÄ¿£¬2011.01-2015.12£¬100ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
8.ÏÈÌìÐÔÊÓÍøĤÅüÁÑÊó¶¯ÎïÄ£ÐÍÖƱ¸¼°RS1»ùÒò¸ÉÔ¤ÖÎÁƵÄʵÑéÑо¿£¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2010.01-2012.12, 31ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
9.ÈËת»ùÒò½ÇĤÄÚƤϸ°ûÖƱ¸¼ø¶¨ÓëÒÆÖ²¼°Æä»úÖÆÑо¿£¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2005.01-2005.12£¬8ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
10.ת»ùÒò½ÇĤ¸Éϸ°ûÒÆÖ²ÖÎÁƸÉϸ°ûȱËð¼²²¡µÄ»úÖÆÑо¿£¨¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬2002.01-2004.12, 17ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË £©
11.¹ÇËè¼ä³äÖʸÉϸ°ûÒÆÖ²ÖÎÁƽÇĤ¸Éϸ°ûȱËðµÄʵÑéÑо¿£¨ÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð£¬2005.01-2006.12, 4ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
12.ת»ùÒò½ÇĤ¸Éϸ°ûÒÆÖ²ÖÎÁƸÉϸ°ûȱËð¼²²¡µÄ»úÖÆÑо¿£¨ÁÉÄþÊ¡×ÔÈ»¿Æѧ»ù½ð£¬2002.01-2004.12, 6ÍòÔª£¬ÏîÄ¿Ö÷³ÖÈË£©
´ú±íÎÄÕ£º
1. Shifeng Fang, Xiang Ma*, Suping Guo, Jianmin Lu. microRNA-126 inhibits the cell proliferation and invasion in diabetic retinitis model via targeting IRS-1. Oncol Lett.£¨Í¨Ñ¶×÷Õߣ©£¨IF=1.554£©
2. Shaoyi Liu#*, Xiaofang Du#, Xiang Ma, Jianlian Gu, Jianmin Lu, Lusheng Ma. Low plasma levels of brain derived neurotrophic factor are potential risk factors for diabetic retinopathy in Chinese type 2 diabetic patients. Mol Cell Endocrinol. **: 152-158. (IF=4.105)
3. Zhuo Ye, Yan-Li Ji, Xiang Ma*, Jian-Guo Wen, Wei Wei, Shu-Man Huang. Pharmacokinetics and distributions of bevacizumab by intravitreal injection of Bevacizumab-PLGA Microspheres in Rabbits. Int J Ophthalmol. 20158(4)653-658. £¨Í¨Ñ¶×÷Õߣ©(IF=0.705)
4. X.Ma, XX.Li*, LH.Wang. Novel XLRS1 Gene Mutations Cause X-linked Juvenile Retinoschisis in Chinese Families. Japanese Journal of Ophthalmology. 200852(1):48-51.£¨µÚÒ»×÷Õߣ©(IF=1.257)
5. X.Ma, P Ottino, and NG.Bazan*. PAF Induces Corneal Neovascularization and Upregulates VEGF Expression in Endothelial Cells. Investigative Ophthalmology & Visual Science. 200445(9):2915-2921. £¨µÚÒ»×÷Õߣ©(IF=3.577)
6. ¸ß½õÕ¹£¬ÂíÏè*. Usher×ÛºÏÕ÷»ùÒò¼°Æäµ°°×Ñо¿.ÖлªÑ۵ײ¡ÔÓÖ¾.201632(3):342-345.£¨Í¨Ñ¶×÷Õߣ©(CSCDºËÐÄÆÚ¿¯)
7. ÀîÑï,ÂíÏè*,¬½¨Ãñ.ÓÕµ¼¶àÄܸÉϸ°û·Ö»¯³ÉÊÓÍøĤɫËØÉÏƤϸ°ûµÄÑо¿½øÕ¹.ÖлªÑ۵ײ¡ÔÓÖ¾.201531(2):212-214.£¨Í¨Ñ¶×÷Õߣ©(CSCDºËÐÄÆÚ¿¯)
8. ÇØÐãºç,¬½¨Ãñ,ÉÛÃ÷Ñô,ÕÅÕäÕä,ËïÏþ¾§,ÂíÏè*.NotchÐźŶԸßÌÇÓÕµ¼ÈËÊÓÍøĤѪ¹ÜÄÚƤϸ°ûµòÍöµÄ±£»¤×÷ÓÃ.ÑÛ¿ÆнøÕ¹.201535(9):6-10.£¨Í¨Ñ¶×÷Õߣ©(¹ú¼ÒºËÐÄÆÚ¿¯)
9. ´ÞÀö,ÂíÏè*,ÕÔÑÞ»Ô.ÈËÆê¾²ÂöÄÚƤϸ°ûÒÆÖ²ÖÎÁƽÇĤÄÚƤ¹¦ÄÜË¥½ßµÄ¶¯ÎïʵÑéÑо¿.¹ú¼ÊÑÛ¿ÆÔÓÖ¾.201414(6):1010-1012.£¨Í¨Ñ¶×÷Õߣ©(¹ú¼ÒºËÐÄÆÚ¿¯)10. ¬½¨Ãñ,ÂíÏè*.Ê÷ͻ״ϸ°ûÔÚ½ÇĤÏà¹Ø¼²²¡ÖеÄ×÷ÓÃ.ÖлªÑÛÊÓ¹âѧÓëÊÓ¾õ¿ÆѧÔÓÖ¾.201315(7):445-448.£¨Í¨Ñ¶×÷Õߣ©(CSCDºËÐÄÆÚ¿¯)

½ÌÓý±³¾° :
1987Äê±ÏÒµÓÚ´óÁ¬Ò½¿Æ´óѧҽÁÆϵ£¬»ñҽѧѧʿѧλ£»1994Äê±ÏÒµÓÚ´óÁ¬Ò½¿Æ´óѧÑо¿ÉúÔº£¬»ñÑÛ¿Æѧ˶ʿѧλ£»1996ÄêÖÁ1997ÄêÓÚÃÀ¹úMiami´óѧ£¬ÊÀ½çÖøÃûÈ«ÃÀÅÅÃûµÚÒ»µÄBascom PalmerÑÛ¿ÆÑо¿Ëù²©Ê¿ºóÑо¿£»1997ÄêÖÁ2001ÄêÓÚÃÀ¹úLouisianaÖÝÁ¢´óѧҽѧԺÑÛ¿ÆÖÐÐIJ©Ê¿ºóÑо¿¡£2005Äê±ÏÒµÓÚ±±¾©´óѧҽѧ²¿£¬»ñÑÛ¿Æѧ²©Ê¿Ñ§Î»¡£